跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERIBULINA STADA 0,44 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ERIBULINA STADA 0,44 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
ERIBULINA STADA 0,44 MG/ML SOLUCION INYECTABLE EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 31, 2023
Approval ID
85b23719d1e4dab7
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
85b23719d1e4dab7
Drug Cima Aemps Name
ERIBULINA STADA 0,44 MG/ML SOLUCION INYECTABLE EFG
Register Number
89127
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2023-10-31
Dosage Form
SOLUCIÓN INYECTABLE
Dose
0,44 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Laboratorio Stada S.L.
Active Ingredients
ERIBULINA MESILATO
0,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 31, 2023
Approval ID
85b23719d1e4dab7
Type
Standard
Back to CIMA-AEMPS Approvals
